Paper36929735
Treatment of status epilepticus: Physiology, pharmacology, and future directions.
Sankar R. Epilepsia Open, 2023. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Treatment of status epilepticus: Physiology, pharmacology, and future directions. Papers, record 36929735. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36929735
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Status Epilepticus | Major topic |
| Humans | |
| Retrospective Studies | |
| Forecasting |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31063770 | Effects of cenobamate (YKP3089), a newly developed anti-epileptic drug, on voltage-gated sodium channels in rat hippocampal CA3 neurons. | Eur J Pharmacol | 2019 | https://conductscience.org/library/papers/31063770 | PubMed |
| 2 | 18652365 | Persistent Na-channels: origin and function. A review. | Acta Biol Hung | 2008 | https://conductscience.org/library/papers/18652365 | PubMed |
| 3 | 25819944 | Single versus combinatorial therapies in status epilepticus: Novel data from preclinical models. | Epilepsy Behav | 2015 | https://conductscience.org/library/papers/25819944 | PubMed |
| 4 | 15944379 | Status epilepticus increases the intracellular accumulation of GABAA receptors. | J Neurosci | 2005 | https://conductscience.org/library/papers/15944379 | PubMed |
| 5 | 31553050 | Excitatory GABAergic signalling is associated with benzodiazepine resistance in status epilepticus. | Brain | 2019 | https://conductscience.org/library/papers/31553050 | PubMed |
| 6 | 15613639 | Cultured Hippocampal Pyramidal Neurons Express Two Kinds of GABAA Receptors. | Mol Pharmacol | 2005 | https://conductscience.org/library/papers/15613639 | PubMed |
| 7 | 32325146 | Positive allosteric modulation of GABAA receptors by a novel antiepileptic drug cenobamate. | Eur J Pharmacol | 2020 | https://conductscience.org/library/papers/32325146 | PubMed |
| 8 | 17941842 | A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation. | Epilepsia | 2008 | https://conductscience.org/library/papers/17941842 | PubMed |
| 9 | 25962657 | Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit. | Epilepsy Behav | 2015 | https://conductscience.org/library/papers/25962657 | PubMed |
| 10 | 22829271 | Calcium-permeable AMPA receptors are expressed in a rodent model of status epilepticus. | Ann Neurol | 2012 | https://conductscience.org/library/papers/22829271 | PubMed |
| 11 | 24001085 | Neuroactive steroids for the treatment of status epilepticus. | Epilepsia | 2013 | https://conductscience.org/library/papers/24001085 | PubMed |
| 12 | 28377128 | Enhanced AMPA receptor-mediated neurotransmission on CA1 pyramidal neurons during status epilepticus. | Neurobiol Dis | 2017 | https://conductscience.org/library/papers/28377128 | PubMed |
| 13 | 1337440 | Translocation and autophosphorylation of brain calmodulin kinase II in status epilepticus. | Epilepsy Res Suppl | 1992 | https://conductscience.org/library/papers/1337440 | PubMed |
| 14 | 17628510 | Analysis of resurgent sodium-current expression in rat parahippocampal cortices and hippocampal formation. | Brain Res | 2007 | https://conductscience.org/library/papers/17628510 | PubMed |
| 15 | 12801796 | GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery? | Drug Discov Today | 2003 | https://conductscience.org/library/papers/12801796 | PubMed |
| 16 | 23197747 | Efficacy and safety of ketamine in refractory status epilepticus in children. | Neurology | 2012 | https://conductscience.org/library/papers/23197747 | PubMed |
| 17 | 36609129 | Why ketamine. | Epilepsy Behav | 2023 | https://conductscience.org/library/papers/36609129 | PubMed |
| 18 | 23758557 | Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. | Epilepsia | 2013 | https://conductscience.org/library/papers/23758557 | PubMed |
| 19 | 19332332 | Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models. | Neurotherapeutics | 2009 | https://conductscience.org/library/papers/19332332 | PubMed |
| 20 | 25927480 | Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications. | J Med Chem | 2015 | https://conductscience.org/library/papers/25927480 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41773460 | Defining the end point of status epilepticus: A scoping review and framework for standardization. | Epilepsia | 2026 | https://conductscience.org/library/papers/41773460 | PubMed |
| 41137579 | Respiratory dysfunction and fatal apnea during pilocarpine-induced status epilepticus. | Epilepsia | 2026 | https://conductscience.org/library/papers/41137579 | PubMed |
| 40956087 | Status epilepticus: Updates on mechanisms and treatments. | Epilepsia Open | 2025 | https://conductscience.org/library/papers/40956087 | PubMed |
| 39766288 | Inhibitory Effects of Cenobamate on Multiple Human Cardiac Ion Channels and Possible Arrhythmogenic Consequences. | Biomolecules | 2024 | https://conductscience.org/library/papers/39766288 | PubMed |
| 38930098 | New Pharmacological Therapies in the Treatment of Epilepsy in the Pediatric Population. | J Clin Med | 2024 | https://conductscience.org/library/papers/38930098 | PubMed |
| 37977814 | Neurosteroids as Novel Anticonvulsants for Refractory Status Epilepticus and Medical Countermeasures for Nerve Agents: A 15-Year Journey to Bring Ganaxolone from Bench to Clinic. | J Pharmacol Exp Ther | 2024 | https://conductscience.org/library/papers/37977814 | PubMed |
| 37629678 | Cenobamate (YKP3089) and Drug-Resistant Epilepsy: A Review of the Literature. | Medicina (Kaunas) | 2023 | https://conductscience.org/library/papers/37629678 | PubMed |
| 36929735 | Treatment of status epilepticus: Physiology, pharmacology, and future directions. | Epilepsia Open | 2023 | https://conductscience.org/library/papers/36929735 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36929735
GET https://conductscience.org/api/papers/v1/36929735/references?page=2